EquiReason
Pricing

Every company is open on every plan. Plans differ by how deep the evidence goes.

Start free to read the market on any company we cover — financials, price, and our full read on a few companies each month. Analyst opens our verdict and the measured evidence underneath it on every company, with alerts. Research Pro adds position-level ownership data, the time series behind every number and market-wide discovery, and Teams & Data puts it in front of a whole desk.

  • No index restriction on any plan
  • Seven-day Research Pro trial, no card
  • Yearly billing is two months free
  • One account, both surfaces — the plan you buy here works in the iPhone app
FreeRead the market
$0forever

 

Every company, every day — the market in plain language, and our full read on three companies a month.

For the curious investor, and for anyone weighing the product up.

  • What you get
  • Daily market read, sector map, movers, confirmed trend board
  • Financial statements, multiples, five-year price chart, live price and calendar — on every company we cover
  • Watchlist for one company
  • Our verdict and the full evidence behind it on three companies each month
  • Not included
  • Verdict and evidence beyond those three companies
  • Fund-by-fund and trade-by-trade ownership detail
  • Market-wide discovery screens, alerting and export
Start Free
AnalystDo the work
$79/ month

 

The evidence under every verdict — for every company, without limits.

For the serious individual investor, the independent analyst and the person running a family portfolio.

  • What you get
  • Our verdict, score, confidence band, thesis, reasons and counter-thesis — on every company we cover
  • The whole evidence layer, unlimited companies: segment, product, geography and customer splits with quarterly movement
  • Quality subgroups, forensic accounting scan and the GAAP-vs-adjusted comparison
  • 8-K chronology and agreement filings, guidance language, the change layer, the expectation gate, the peer multiple table
  • Every evidence badge and the full stage-gate table behind the verdict
  • Ranked opportunity list with full filters, trend beneficiary pools and bulk scanning, with second-order chains flagged
  • Forming-theme radar: themes we can measure before they are established
  • Fund, insider and analyst summaries, plus the trade-by-trade insider record
  • A larger watchlist, alerts and the basic notification classes
  • Daily verdict cards, theme scorecards and the house-view record
  • Not included
  • KPI series, within-sector percentiles, eight-quarter trajectories and full second-order chains
  • Fund-by-fund 13F breakdown and the quarterly flow series
  • Analyst revision timeline, options positioning, government award flow
  • Market-wide discovery screens, segment-drift tracking, track record
  • Export and API
Most popular
Research ProProve it, over time and across the market
$149/ month

 

Position-level ownership data, the full time series behind every number, market-wide discovery and every alert class.

For the professional and semi-professional analyst, the small-fund researcher and the family office.

  • What you get
  • Everything in Analyst
  • KPI series, within-sector percentiles, eight-quarter trajectories and full second-order chains
  • Fund-by-fund 13F breakdown with the quarterly ownership flow series
  • Analyst target and recommendation timeline with the revision series
  • Options positioning, the full short-interest series, public and defence award flow
  • Market-wide discovery: insider screening, 13F flow, short interest and SEC filing intelligence
  • Every alert class, segment-drift tracking, saved screens and the stamped track record
  • Unlimited watchlist and alerts, plus CSV and JSON export
  • Not included
  • API access
  • Data licensing
  • Multiple seats — that is the Teams plan
Teams & DataPut it in your stack
Contact us

 

Research Pro for the whole desk, plus your data engagement.

For funds, family offices, research teams and data buyers. Sold under contract, not through checkout.

  • What you get
  • Up to five Research Pro seats
  • Coverage and workflow onboarding
  • Priority data-quality review and a custom universe definition
  • API access and bulk delivery, scoped by agreement
  • Data licensing is a separate contract
  • Not included
  • Price, analyst, options and short data are licensed from providers and are never resold in any package
Start your 7-day Research Pro trial — no card required.

Full depth on every company. When the week ends you drop to Free — nothing is charged, and there is nothing to cancel. The trial does not use up your monthly free reports.

Already have an account?

Everyone who signed up before these plans went live keeps full access, permanently, as a founding member. You carried the product while it had no paywall — nobody wakes up to find yesterday's screen locked. Your plan status is shown on your account page.

Full comparison

Line by line, what each plan opens.

82 rows, grouped the way the product is layered. Every plan searches and opens every company we cover — the difference is how deep the evidence goes.

Feature availability by plan. A dash means the plan does not include that row.
FeatureFree$0Analyst$79 / moResearch Pro$149 / moTeams & DataContact us
Market viewOpen on every plan, on every company we cover.
Daily market read and macro regime, in plain language
Leading indicators, sector map and movers
House view card and desk note
House view scorecard — the stamped 30-day recordHeadline only
Confirmed trend board
Forming-theme radar — themes before they are established
Theme file: definition, mechanism and related themes
Search, open and list every company we cover
Since-last-visit and your-companies status stripWatchlist symbolsWatchlist symbols
Company profileOpen on every plan, on every company we cover.
Identity, profile, financial statements and multiples
Five-year price chart, live price and return context
Trend link: label, lifecycle, exposure and macro fit
Earnings countdown and next catalyst
Company verdictWhat we think, and why — on every company with Analyst. Free opens it on a few companies each month.
Verdict, score, confidence band and one-line thesis3 companies / month
Reasons and counter-thesis3 companies / month
Score composition strip — where the score came from3 companies / month
Confidence reasons and evidence grade3 companies / month
Source-coverage grid — what the verdict is not relying on3 companies / month
Quality score, Altman Z and risk caps3 companies / month
Attractiveness verdict and its three axes3 companies / month
Evidence layerThe measured material under the verdict. Free opens it on a few companies each month; Analyst removes the limit. Time series and within-sector comparison are Research Pro.
Stage-gate table behind the verdict3 companies / month
Full evidence file — every badge with its weight, confidence and date3 companies / month
Segment revenue split with year-on-year movement3 companies / month
Segment quarter-on-quarter and prior-quarter share3 companies / month
Product, geography and customer revenue splits3 companies / month
The company's own operational KPI series, period-stamped
Revenue share behind each trend link3 companies / month
Quality subgroups3 companies / month
Within-sector percentiles
Forensic accounting: accruals, cash conversion, receivables gap3 companies / month
GAAP-vs-adjusted comparison and non-GAAP quotes3 companies / month
Peer multiple table with coverage and peer count3 companies / month
Change layer: flags and delivery record3 companies / month
Eight-quarter trajectory
Filing delta summary and evidence-change tracker3 companies / month
Expectation gate and pricing state3 companies / month
12-month 8-K chronology, agreement filings and filter chips3 companies / month
Guidance language from transcripts3 companies / month
Measured trend evidence ladder, peer position and SEC validation3 companies / month
Signal tensions — where the evidence contradicts itself3 companies / month
Ownership and insidersWhat other participants are doing. Summaries at Analyst; the position-level detail at Research Pro.
Institutional 13F summary: filers, added, trimmed, new, exited3 companies / month
Fund-by-fund 13F breakdown with position size
Quarterly institutional flow series
Insider summary: buys, sells and the pre-scheduled split3 companies / month
Trade-by-trade insider records: date, title, size, plan status
Short interest summary3 companies / month
Full short-interest series with as-of history
Options positioning
Analyst summary: targets, counters and revision rate3 companies / month
Analyst target and recommendation timeline
Public and defence award flow
Funds-vs-insider contradiction note3 companies / month
Discovery screensFinding the name instead of looking it up. Your own screens at Analyst; market-wide scanning at Research Pro.
Ranked opportunity list3 rows250 rowsCustom universe
Screen filters: sector, lane, tier, catalystSector only
Evidence badges on list rowsCount only
Trend beneficiary poolsCount only
Measured share stamps and evidence rung on pool rows
Cascade and second-order chainsFlagged only
Bulk multi-symbol scan
Catalyst feed and event-to-symbol searchLatest few
Market-wide insider screen
Market-wide 13F flow screen
Market-wide short interest screen
SEC filing intelligence screen
Market-wide theme-breadth scan
Saved screens and filter sets
Automation and alertsThe desk telling you what changed, instead of you going to look.
Watchlist symbols150Unlimited
Alerts you set yourself10Unlimited
Basic notification classes: earnings countdown, verdict change
Edge classes: agreements, adverse filings, guidance, insider clusters
Segment-drift tracking
Daily verdict cards and research notes
Theme scorecardsHeadline only
Stamped track record
Mobile push deliveryBasic classes
Data accessViewing is not redistribution. Licensed price, analyst, options and short data never leave the product, in any package.
Report sharing link
JSON report export
CSV export: opportunity list, financials, KPI series10,000 rows
API accessBy agreement
Data licensing — our own SEC-sourced layer onlySeparate contract
Seats115
Onboarding and priority data-quality review
What it is built on

Primary sources, read directly.

The evidence layer is assembled from company disclosure rather than commentary. Market, analyst and options data come from licensed providers and stay inside the product.

  • SEC filingsAnnual, quarterly and current reports, read line by line
  • XBRL financial factsNormalized, period-stamped, checked against the filing
  • 13F holdingsInstitutional positions, unit-corrected and aggregated
  • Form 4 insider recordsTrade by trade, including whether a sale was pre-scheduled
How EquiReason Thinks

One research chain, not disconnected scores.

  • Every plan sees every company we cover — plans differ by how deep the evidence goes, never by which names you are allowed to open
  • You pay for normalized coverage, verified linkage, decision context and proof — not tokens or raw public-data resale
  • Measured calls are timestamped when made and evaluated forward — never backfilled
  • Coverage-limited layers show their source and freshness; scoped API, bulk delivery and SLA are sold only by agreement
  • Data licensing covers our own SEC-sourced layer only. Price, analyst, options and short data stay inside the product
Questions

Before you decide.

When am I charged?

When you complete checkout, and then at the start of each billing period — monthly or yearly, whichever you chose. The seven-day trial takes no card, so nothing is charged while it runs.

Can I cancel at any time?

Yes. Cancelling, changing your card and downloading invoices all happen in the billing portal, which opens from your account page. Your plan stays open until the end of the period you have already paid for. There is no cancellation fee and no minimum term.

Is the trial really card-free?

Yes. We never ask for a card to start it. When the seven days end you drop to Free automatically — nothing is charged and there is nothing to cancel. The trial also does not use up that month's free reports.

Do cheaper plans see fewer companies?

No. Every plan can search, open and list every company we cover, with no index restriction. Plans differ by how deep the evidence goes, not by which companies you are allowed to look at.

Where does the data come from?

Company filings from SEC EDGAR — annual, quarterly and current reports, XBRL financial facts, institutional 13F holdings and Form 4 insider transactions — plus earnings-call language, and market and analyst data from licensed providers. Every layer states its source and freshness, and missing evidence is shown rather than hidden.

Is this investment advice?

No. EquiReason is a research tool. It shows the evidence, the reasoning and the limits of both, so you can reach your own conclusion. It does not tell you what to do with your money, and we are not licensed advisers.

Who handles billing, invoices and VAT?

Payments run through Lemon Squeezy as Merchant of Record. They collect and remit sales tax and VAT where it applies and issue your invoice. Card details never reach our servers. The charge shows up on your statement as Lemon Squeezy rather than EquiReason — if you do not recognise a payment, that is almost always why.

How do I buy Teams & Data?

By talking to us, not through checkout. Seats, coverage scope and the data engagement are agreed first, so Teams & Data is sold under contract. Use the Contact sales button on the plan and we will come back with the scope and the paperwork.

Can I change plans later?

Yes. An upgrade opens the extra depth as soon as the payment clears; a downgrade takes effect at the end of the period you have paid for. Your watchlist, alerts and saved work stay on your account either way.

Start with the free read. Pay when you need the proof.

Open any company, see the verdict and the counter-thesis, and decide for yourself whether the evidence underneath is worth paying for.

Research platform — not investment advice. Licensed price, analyst, options and short data are never resold in any package, and thresholds and weights are not part of any licence.